Interaction between L-arginine: No system and cyclooxygenase metabolic products of arachidonic acid in coronary autoregulation

Journal of Physiology and Pharmacology

Volumn 50, Issue 1, 1999, Pages 63-74

  Jakovljevic V L J ^d,e   Kostic M M ^d   Mujovic, V M ^a   Bojic M ^b   Nedeljkovic T I ^c   Djuric D M ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b Institute of Cardiovascular Disease Dedinje   (Serbia)

^c CHC Kragujevac   (Serbia)

^d UNIVERSITY OF KRAGUJEVAC   (Serbia)

^e Faculty of Medicine   (Serbia)

Author keywords

Coronary autoregulation; Indomethacin; L NAME; Nitric oxide; Rat heart

Indexed keywords

ADENOSINE; ARACHIDONIC ACID; ARGININE; CYCLIC AMP; CYCLIC GMP; INDOMETACIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANIMAL TISSUE; ARACHIDONIC ACID METABOLISM; ARTICLE; BLOOD VESSEL TONE; CARDIOVASCULAR AUTOREGULATION; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; ENZYME INHIBITION; ISOLATED HEART; MALE; NONHUMAN; PERFUSION PRESSURE; PROTEIN PROTEIN INTERACTION; RAT;

EID: 0032951492     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Dole WP. Autoregulation of coronary circulation. Prog Cardivasc Dis 1987; 29: 293-323.
2. Kuo L, Davis MJ, Chilian WM. Myogenic activity in isolated subepicardial and subendocardial coronary arterioles. Am J Physiol 1988; 255: H1558-H1562.
3. Harder DR. Pressure-induced myogenic activation of cat cerebral arteries is dependent on intact endothelium. Circ Res 1987; 60: 102-107.
4. Kuo L, Davis MJ, Chilian WM. Endothelium-dependent flow-induced dilation of isolated coronary arterioles. Am J Physiol 1990; 259: H1063-H1070.
5. Jones CJH, Kuo L, Davis MJ, Chilian WM. Regulation of coronary blood flow: coordination of heterogenous control mechanisms in vascular microdomains. Cardiovasc Res 1995; 29: 585-596.
6. Needleman P, Turk J, Jakschik BA, Morrison AR, Lefkowith JB. Arachidonic acid metabolism. Annu Rev Biochem 1986; 55: 69-102.
7. Kauser K, Clark JE, Masters BS, Ortiz de Montellano PR, Ma YH, Harder DR, Roman RJ. Inhibitors of cytochrome P-450 attenuate the myogenic response of dog renal arcuate arteries. Circ Res 1991; 68: 1154-1163.
8. Harder DR, Campbell WB, Roman RJ. Role of cytochrome P-450 enzymes and metabolites of arachidonic acid in the control of vascular tone. J Vasc Res 1995; 32(2): 79-92.
9. Rees DD, Palmer RJ, Moncada S. Nitric oxide and microcirculation. In: Nitric Oxide from L-Arginine: A bioregulatory System, Moncada S, Higgs EA (eds). Amsterdam, Excerpta Medica, 1990, 427-438.
10. Kostić MM, Schrader J. Role of nitric oxide in reactive hyperemia of the guinea pig heart. Circ Res 1992; 70: 208-212.
11. Ueeda M, Scott SK, Silvia SK, Olsson RA. Nitric oxide modulates coronary autoregulation in the guinea pig. Circ Res 1992; 70: 1296-1303.
12. Kostić MM, Petronijevic MR. Interplay of nitric oxide and histamine in the regulation of coronary reactive hyperemia and coronary autoregulation. In: Mediators in the Cardiovascular System: Regional Ischemia, Schroer K, Pace-Asciak CR (eds). Basel, Birkhaeuser Verlag, 1995, 145-149.
13. Kostić MM, Petronijević MR, Jakovljevic VLJ. Role of nitric oxide (NO) in the regulation of coronary circulation. Physiol Res 1996; 45(4): 273-278.
14. Rosić GL, Stojadinović ND, Petronijevic MR, Kostić MM. Histamine regulation of reactive hyperemia in the isolated guinea pig heart. Iugosl Physiol Pharmacol Acta 1993; 29: 147-154.
15. Kostić MM, Jakovljević VLJ. Role of histamine in the regulation of coronary circulation. Physiol Res 1996; 45(4): 297-303.
16. Schrader J, Haddy FJ, Gerlach E. Release of adenosine, inosine and hypoxanthine from the isolated guinea pig heart during hypoxia, flow-autoregulation and reactive hyperemia. Pflügers Arch 1977; 369: 1-6.
17. Kostić MM. A new bioregulatory system: nitric oxide from L-arginine. Iugosl Physiol Pharmacol Acta 1993; 29(1): 3-34.
18. Emery CJ. Vasodilator action of the S-nitrosothiol, SNAP, in rat isolated perfused lung. Physiol Res 1995; 44: 1-24.
19. Moncada S, Vane JR. The role of prostacyclin in vascular tissue. Fed Proc 1979; 38: 66-71.
20. 15 N]nitrate in biological fluids. Anal Biochem 1982; 126: 131-138.
21. Brooker G, Harper JF, Terasaki WL and Moylan RD. Radioimmunoassay of cyclic AMP and cyclic GMP. Adv Second Messenger Phosphoprotein Res 1979; 10: 1-33.
22. Gilman AG. A protein binding assay for adenosine 3′5′-cyclic monophosphate. Proc Natl Acad Sci USA 1970; 67(1): 307-312.
23. Jensen MH, Jorgensen S: Hypoxanthine. In: Methods of Enzymatic Analysis, Bergmeyer HU (ed). New York, Academic Press. 1974, 1941-1945.
24. Gryglewski RJ, Chlopicki S, Niezabitowski P. Enodthelial control of coronary flow in perfused guinea-pig heart. Basic Res Cardiol 1995; 90: 119-124.
25. Needleman P, Kulkarni PS, Raz A. Coronary tone modulation: Formation and actions of prostaglandins, endoperoxides and thromboxanees. Science 1977; 195: 409-412.
26. Needleman P, Wyche P, Raz A. Platelet and blood vessel arachidonate metabolism and interactions. J Clin Invest 1979; 63: 345-349.
27. Dole WP, Nobuyuki Y, Bishop VS, Olsson RA. Role of adenosine in coronary blood flow regulation after reductions in perfusion pressure. Circ Res 1985; 56: 517-524.
28. Bojić M, Durić D. Endothelium in cardiovascular medicine. Belgrade, Institute of Cardiovascular Disease "Dedinje", 1997 (Serbian).
29. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43(2): 109-142.
30. Schroer K, Koehler P, Mueller M, Peskar BA, Roesen P. Prostacyclin-thromboxanee interactions in the platelet-perfused in vitro heart. Am J Physiol 1981; 241: H18-H25.
31. Mujović VM, Nićin S, Simeunović S, Milošević A, Radovanović ND. Prostacyclin: A new treatment of patients following coronary artery bypass surgery and total endarterectomy. Cardiology 1992; 13(1-2): 23-30.
32. Mujović VM. Autacoid system. Belgrade, Science, 1998: pp. 144 (Serbian).
33. Palmer RMJ, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988; 333: 664-666.
34. Kelm M, Schrader J. Comparsion of nitric oxide formation in cultured endothelial cells and isolated guinea pig hearts. In: Nitric oxide from L-arginine: A bioregulatory system, Moncada S, Higgs EA(eds). Amsterdam, Elsevier, 1990, pp. 47-54.
35. 2+ -independent nitric oxide synthase in the myocardium. Br J Pharmacol 1992; 105: 575-580.
36. Kelly RA, Balligand JL, Smith TW. Nitric Oxide and Cardiac Function. Circ Res 1996; 79(3): 363-380.
37. Kostić MM, Schrader J. Platelet cGMP, but not cyclic AMP, is significantly changed during single passage through the heart (abstract). J Mol Cell Cardiol 1991; 23: 89.
38. Node K, Kitakaze M, Kosaka H et al. Plasma nitric oxide end products are increased in the ischemic canine heart. Biochem Biophys Res Commun 1995; 211: 370-374.
39. Roesen R, Kuhn A, Schroes K. Arachidonic acid-induced relaxation of coronary arteries is enhanced by indomethacin (abstract). Proceedings of the International Union of Physiological Sciences 1980; 14: 672.
40. Schroer K, Moncada S, Ubatuba B, Vane JR. Transformation of arachiodnic acid and prostaglandin endoperoxides by the guinea pig heart. Formation of RCS and prostacyclin. Eur J Pharmacol 1978; 47: 103-114.
41. Ohno M, Oshiai M, Taguchi J, Hara K, Akatsuka N, Kurokawa K. Stretch may enhance the release of endothelium-derived relaxing factor in rabbit aorta. Biochem Biophys Res Commun 1990; 173: 1038-1042.